» Articles » PMID: 37530601

Three Daily Intraperitoneal Injections of Sub-anesthetic Ketamine Ameliorate Activity-based Anorexia Vulnerability of Adult Female Mice

Overview
Publisher Wiley
Specialty Social Sciences
Date 2023 Aug 2
PMID 37530601
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify ketamine's dosing schedule that ameliorates voluntary food restriction, hyperactivity and body weight loss of adult mice undergoing activity-based anorexia (ABA), an animal model of anorexia nervosa.

Method: Female and male C57BL6 mice underwent three cycles of ABA, starting from mid-adolescence. ABA vulnerability was compared within and across two groups of animals: those injected intraperitoneally with 30 mg/kg ketamine for three consecutive days (30mgKetx3) during the second ABA in late adolescence (ABA2) or with vehicle only (Vx3).

Results: Vx3 females and males exhibited individual differences in wheel running and weight retention during first ABA in mid-adolescence (ABA1), ABA2, and third ABA in adulthood (ABA3). Their wheel running correlated with anxiety-like behavior. During ABA1 and ABA3, weight gain of Vx3 females (but not males) after food consumption correlated negatively with food-anticipatory activity (FAA) preceding the feeding hours, indicating that females with higher levels of running restrict feeding more and persistently. This paradoxical relationship confirms earlier findings of ABA females without ketamine treatment, capturing the maladaptive behaviors exhibited by individuals diagnosed with anorexia nervosa. By contrast, 30mgKetx3 had an effect on both sexes of reducing hyperactivity during the feeding hours acutely and reducing anxiety-like behavior's contribution to running. For females, only, 30mgKetx3 acutely improved the extent of compensatory food consumption relative to FAA and improved weight retention during ABA3, 12 days post ketamine in adulthood.

Discussion: Sub-anesthetic ketamine evokes behavior-specific ameliorative effects for adult mice re-experiencing ABA, supporting the notion that multiple doses of ketamine may be helpful in reducing relapse among adults with anorexia nervosa.

Public Significance Statement: This study examined whether ketamine reduces anorexia-like behaviors in adult mice. Three daily sub-anesthetic ketamine injections suppress wheel running during and leading up to the hours of food availability and enable animals to compensate better for weight loss associated with excessive exercise by eating more. These findings suggest that ketamine may help adult females diagnosed with anorexia nervosa but also point to sex- and age-related differences in the action of ketamine.

Citing Articles

Enhancing the Connection Between Basic and Applied Research in Eating Disorders: Steps Toward More Effective Translation.

Hildebrandt B, Goldschmidt A Int J Eat Disord. 2024; 57(7):1401-1405.

PMID: 38940300 PMC: 11262957. DOI: 10.1002/eat.24239.


Sex-dependent circadian alterations of both central and peripheral clock genes expression and gut-microbiota composition during activity-based anorexia in mice.

Salaun C, Courvalet M, Rousseau L, Cailleux K, Breton J, Bole-Feysot C Biol Sex Differ. 2024; 15(1):6.

PMID: 38217033 PMC: 10785476. DOI: 10.1186/s13293-023-00576-x.


Ketamine ameliorates activity-based anorexia of adolescent female mice through changes in GluN2B-containing NMDA receptors at postsynaptic cytoplasmic locations of pyramidal neurons and interneurons of medial prefrontal cortex.

Li J, Temizer R, Chen Y, Aoki C Brain Struct Funct. 2024; 229(2):323-348.

PMID: 38170266 DOI: 10.1007/s00429-023-02740-w.